Andrew Hull - 24 Jan 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Bruce Colwill, attorney-in-fact for Mr. Andrew Hull
Issuer symbol
INM
Transactions as of
24 Jan 2022
Transactions value $
$0
Form type
4
Filing time
24 Jan 2022, 15:17:49
Previous filing
30 Dec 2021
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -30.3K -65.27% $0.00 16.1K 24 Jan 2022 Common shares 30.3K $2.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$3.63 using an exchange rate of C$1.2554 = $US1.00